Glp-1 For Type 2 Diabetes In Elderly Patients

Mounjaro (tirzepatide) is the first and only, once-weekly approved single-molecule GIP and GLP-1 receptor agonist that helps lower A1C for adults with type 2 diabetes.

Type 1 diabetes; the use of GLP-1receptor agonists, dipeptidyl peptidase 4 (DPP-4) inhibitors, pramlintide, or rapid-acting insulin; a familial or personal history of multiple endocrine neoplasia type 2 or medullary thyroid cancer...

This particular example perfectly highlights why Glp-1 For Type 2 Diabetes In Elderly Patients is so captivating.

This leads to the development of type 2 diabetes. GLP-1 and the One-Stop Shop Approach for Diabetes Treatment. Older diabetic patients have higher risks of hypoglycemia (low blood sugar) and adverse drug events due to diabetic complications.

Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY).